Evaluation of intraoperative and postoperative complications related to lymphadenectomy in ovarian cancer patients (original) (raw)

Abstract

Assessment of the regional lymph node status is an integral part of diagnostics for ovarian cancer patients. Due to the risk of complications, lymphadenectomy for ovarian cancer patients, as a routine treatment procedure, is still a subject of controversy. Therefore, the present study aimed to evaluate the frequency and nature of intraoperative and postoperative complications in ovarian cancer patients treated with surgery. In addition, a comparison of the frequency and nature of surgical complications between patients who underwent lymphadenectomy and those who did not was carried out. A retrospective analysis of 211 consecutive ovarian cancer patients treated with surgery with pelvic and aortic lymphadenectomy (group I), and 258 ovarian cancer patients treated with surgery but without lymphadenectomy (group II) was carried out. All of the patients were treated with complementary chemotherapy. The frequency and nature of the intraoperative and postoperative complications were determined. The most frequent intraoperative complications in the two groups were haemorrhage, urinary system damage and digestive tract damage. The difference in the frequency and nature between the groups was not statistically significant (p=0.683). The most frequent postoperative complications were haemorrhage, intestinal junction dehiscence, eventrations, wound dehiscence, anaemia, wound healing complications and intestinal fistulas. Haemorrhage, eventrations and wound healing complications were more frequent in group I. The difference was statistically significant (p=0.002). Due to postoperative complications, reoperative procedures were necessary in two women in group II (0.78) and in 15 women (7.11%) in group I. The difference was statistically significant (p=0.000). In conclusion, the most frequent intraoperative complications were haemorrhage, urinary system damage and digestive tract damage. The frequency of complication was found to be similar in the two groups. A statistically significant higher rate of postoperative complications, such as haemorrhage, eventrations and wound healing complications was confirmed in the lymphadenectomy group.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (20)

  1. Trope C and Kaern J: Primary surgery for ovarian cancer. Eur J Surg Oncol 32: 844-852, 2006.
  2. Aletti GD, Dowdy S, Podratz KC, et al: Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Am J Obstet Gynecol 195: 1862-1868, 2006.
  3. Panici BP, Maggioni A, Hacker N, et al: Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 97: 560-566, 2005.
  4. Byrom J and Quentin D: Cancer of the ovary. Obstet Gynecol 13: 88-94, 2003.
  5. Angioli R, Plotti F, Palaia I, et al: Update on lymphadenectomy in early and advanced ovarian cancer. Obstet Gynecol 20: 34-39, 2008.
  6. Verleye L, Ottevanger PB, van der Graaf W, et al: EORTG-GCG process quality indicators for ovarian cancer surgery. Eur J Cancer 45: 517-526, 2009.
  7. Ayhan A, Gultekin M, Dursun P, et al: Metastatic lymph node number in epithelial ovarian carcinoma: does it have any clinical significance? Gynecol Oncol 108: 428-432, 2008.
  8. Maggioni A, Panici PB, Dell' Anna T, et al: Randomized study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer 95: 699-704, 2006.
  9. Panici PB, Maggioni A, Hacker N, et al: Systematic aortic and pelvic lymphadenectomy prolonged progression-free survival in advanced ovarian cancer. Gynecol Oncol 7: 209-210, 2005.
  10. Ceccaroni M, D' Agostino G, Ferrandina G, et al: Gynecological malignancies in elderly patients: is age 70 a limit to standard-dose chemotherapy? An Italian Retrospective Toxicity Multicentric Study. Gynecol Oncol 85: 445-450, 2002.
  11. De Poncheville L, Perrotin F, Lefrancq T, et al: Does para- aortic lymphadenectomy have a benefit in the treatment of ovarian cancer that is apparently confined to the ovaries? Eur J Cancer 37: 210-215, 2001.
  12. Chambers SK: Systematic lymphadenectomy in advanced epithelial ovarian cancer: two decades of uncertainty resolved. J Natl Cancer Inst 97: 548-549, 2005.
  13. Chan JK, Munro EG, Cheung MK, et al: Association of lymph- adenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol 109: 12-19, 2007.
  14. Dobbs S and Wiliamson K: Laparoscopic lymphadenectomy in gynecological oncology. Obstet Gynecol 8: 109-112, 1998.
  15. Du Bois A, Reuss A, Pujade-Lauraine E, et al: Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovarie (GINECO). Cancer 115: 1234-1244, 2009.
  16. Chan JK, Urban R, Hu JM, et al: The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Br J Cancer 96: 1817-1822, 2007.
  17. Stratton JF, Tiddy JA and Paterson ME: The surgical management of ovarian cancer. Cancer Treat Rev 27: 111-118, 2001.
  18. Ushijma K: Management of retroperitoneal lymph nodes in the treatment of ovarian cancer. Int J Clin Oncol 12: 181-186, 2007.
  19. Oksefjell H, Sandstad B and Trope C: Ovarian cancer stage IIIC. Consequences of treatment level on overall and progression-free survival. Eur J Gynaecol Oncol 27: 209-214, 2006.
  20. Bidzinski M, Derlatka P, Kubik P, et al: The evaluation of intra and postoperative complications related to debulking surgery with bowel resection in patients with FIGO stage III-IV ovarian cancer. Int J Gynecol Cancer 17: 993-997, 2007.